Lundbeck
Lundbeck is a global pharmaceutical company specialized in brain diseases.
Launch date
Employees
Market cap
AUD10.1b
Enterprise valuation
AUD9.1b (Public information from Sep 2024)
Share price
DKK39.45 LUN.CO
Copenhagen Capital Region of Denmark (HQ)
Corporate Venture Fund: Lundbeckfonden Ventures
No columns specified